FORT: Randomized Trial of Five or Two MRI-Guided Adaptive Radiotherapy Treatments for Prostate Cancer

REVIEW UroToday

Safety and Feasibility of a Shorter Course of Radiation Therapy for Men with Low or Intermediate Risk Prostate Cancer (FORT)

Randomized Phase II Trial of Five or Two MRI-Guided Adaptive Radiotherapy Treatments for Prostate Cancer

Condition: Prostate Cancer
Study ID: NCT04984343